Crypto is entering its fundamentals era.
As revenue becomes a bigger part of how networks are evaluated, Injective is emerging as one of the strongest L1s on revenue relative to valuation.
P/S compares a network’s valuation to the annualized revenue it retains. Put simply, a lower ratio means more revenue generated relative to valuation.
By that measure, Injective ranks 4th across all L1s.
Fundamentals are becoming harder to ignore.
Injective hosted a private lunch forum in Korea, bringing together more than 40 leading Korean institutions and financial giants 🇰🇷
Executives from top-tier banks, securities firms, fintech companies, and asset managers joined the gathering, where our COO @Mirza presented Injective’s institutional stack. LG CNS and @FourPillarsFP also shared their perspectives on the future of onchain tokenization with Injective.
Korea’s financial leaders are exploring what comes next, and Injective is bringing them into the conversation.
#Bitcoin A rare signal is flashing
Every previous bullish stochastic crossover from oversold on the 6-week chart marked the cycle bottom.
Now we're seeing the fifth occurrence.
BITCOIN JUST FLASHED A SIGNAL THAT LED TO A NEW LOW THE LAST THREE TIMES.
The 3-day Stoch RSI, a momentum gauge, just crossed bearish.
The last three times this happened, price dropped to a fresh low.
The chart says down.
But there is a wildcard this time that was not there before. The Clarity Act.
If it passes, the whole backdrop changes, and a catalyst like that can break the pattern the chart is pointing at.
Momentum says lower. Legislation could say otherwise. Watch both.